Introduction
The primary function of B cells is to produce antigen (Ag)-specific antibodies that neutralize and clear pathogens. Antibody (Ab) production is mediated by two populations of effector B cells: memory cells, which circulate throughout the body and rapidly respond to re-encounter with the initiating Ag, and long-lived plasma cells, which constitutively secrete large quantities of high-affinity, isotype-switched Ab. Both populations are generated from naïve B cells during germinal centre (GC) reactions occurring within secondary lymphoid tissues. naïve and memory cells to differentiate into plasmablasts producing IgM, IgG and IgA. 6, 12, 13, 15 Some cytokines induce secretion of particular Ig subclasses by human naïve B cells, with IL-4
and IL-13 inducing IgG4 6,9 and IL-10 and IL-21 inducing IgG1 and IgG3. 11, 12, 16, 17 There is also significant interplay between different cytokines -IL-4 enhances IL-21-induced switching to IgG, 16 and these cytokines synergize to induce IgE. 18 Similarly, TGF-β and IL-10 co-operate to induce IgA production by naïve B cells, 7 and IL-2 enhances the effects of IL-10 on memory B-cell differentiation. 19, 20 On the other hand, IL-4 inhibits IL-21-induced isotype switching to, and secretion of, IgA. 13, 16 IL-21 has emerged as the most potent cytokine influencing human B cells. It induces secretion of IgM, IgG and IgA from all subsets of mature B cells. 13, 21 The IL-21 receptor comprises a specific IL-21R chain and the common gamma chain (γc), an integral component
For personal use only. on April 3, 2017 . by guest www.bloodjournal.org From of the receptors for IL-2, IL-4, IL-7, IL-9 and IL-15. 22 Binding of IL-21 to its receptor activates JAK1 and JAK3, resulting in phosphorylation and activation of STAT1, STAT3 and STAT5, thereby initiating gene transcription and effector function in responding cells. 22 The predominant mechanism underlying IL-21-induced B-cell differentiation is STAT3-mediated induction of BLIMP-1, 12,13,23-25 a transcriptional repressor critical for the generation of plasma cells and normal Ab responses in vivo. 1, 26 Loss-of-function mutations in STAT3 cause Autosomal Dominant Hyper-IgE Syndrome (AD-HIES). 27, 28 A feature of this condition is impaired humoral immunity following infection and vaccination. [29] [30] [31] We have previously established that naïve B cells from these individuals fail to differentiate into Ag-specific memory cells in vivo and Ab-secreting cells in response to IL-21 in vitro. 23 We have now investigated additional mechanisms by which IL-21/STAT3
signalling modulates human B-cell responses and how defects in this pathway contribute to poor serological immunity in patients with immunodeficiencies.
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Methods

Human blood and tissue samples
Buffy coats from healthy donors and spleens from cadaveric organ donors were provided by the Australian Red Cross Blood Service, and tonsillar tissue from patients undergoing tonsillectomy. Peripheral blood was collected from patients with mutations in STAT3, STAT1, IL21R, IL2RG and IL2RA. 21, 23, 32, 33 EBV-transformed lymphoblastoid B-cell lines (LCLs) were established as described. 23 Human experiments were approved by the relevant institutional ethics committees at St Vincent's Hosptial, Royal Prince Alfred Hospital, Sydney Children's Hospital Network, Westmead Hospital, The Canberra Hospital (in Australia), as well as at NIAID/NIH and Rockefeller University. The study was conducted in accordance with the Declaration of Helsinki.
mAbs
The following mAbs were used: FITC-anti-CD20, APC-anti-CD10, APC-anti-IgG, PE-anti-CD27, APC-anti-CD25, PE-anti-IL-2Rβ, PE-anti-IL-2Rγ, APC-anti-CD38, PE-anti-CD4, Alexa
Fluor 647-anti-CXCR5, PE-anti-pSTAT3 (pY705), Alexa Fluor 647-anti-pSTAT1 (pY701), Alexa Fluor 488-anti-pSTAT5 (pY694), APC-anti-IL-2 (BD Biosciences); FITC-anti-CD45RA, PE-anti-IL-21, neutralizing anti-IL-2 (eBioscience); Alexa Fluor 647-anti-CD226 (DNAM1) (Biolegend).
B-cell phenotyping and isolation
Naïve B cells were isolated from peripheral blood, tonsil or splenic mononuclear cells using negative isolation (Invitrogen) followed by sorting naïve B cells (CD20   +   CD27 -CD10 -IgG -) after labelling with specific mAbs (FACSAria; BD). The purity of the recovered population was typically >98%. Microarrays were performed using GeneChip Human Gene 1.0 ST Arrays (Affymetrix).
Microarray data was analysed using GenePattern software (version 3.2.3, Broad Institute, Cambridge, MA). The GEO accession number for the microarray data is GSE51587.
Quantitative PCR
Sorted naïve B cells were cultured for 5 days with CD40L alone or together with IL-21.
Expression of IL2RA (forward, 5'-GAAATGCAAAGTCCAATGCAG-3'; reverse, 5'-AATTCTCTCTGTGGCTTCATTTTC-3') was determined using the Roche LightCycler® 480
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Chromatin Immunoprecipitation Assay
LCLs were fixed with formaldehyde, washed with cold PBS containing Protease Inhibitor Cocktail (Roche), resuspended in Nuclei Buffer and homogenized. Lysates were sonicated, depleted of insoluble material and immunoprecipitated with anti-STAT3 or mouse IgG.
Immunoprecipitated DNA was used as a template for qPCR using SensiMix Probe Master Mix (Bioline) and primers for GAPDH (forward, 5'-TTGCAACCGGGAAGGAAA-3'; reverse, 5'-TAGCCTCGCTCCACCTGACTT-3') and the promoter regions of PRDM1 (forward, 5'-TGCAGGAAGGTGGTAGGAAACGG-3'; reverse, 5'-TCGCTGGTGCGGAAACTGCTT-3') and
IL2RA
(forward, 5'-TGTCATCCCCAAAACTCCCG-3'; reverse, 5'-ACGTCACCAAGTAAAGGGCA-3').
Expression of phosphorylated STATs
LCLs were stimulated with IL-2 or IL-21 alone. Expression of phospho-STAT1, STAT3 or STAT5 was determined as previously described. 18 For personal use only. Figure 1A ). As expected, PRDM1 was not induced in IL-21-stimulated STAT3-deficient naive B cells ( Fig 1A) . Similarly, other genes involved in plasma cell formation -PERP1, 36 XBP1, 26 IGJ, IGKC, IGLC -were also upregulated in normal but not STAT3-deficient naïve B cells in response to IL-21 ( Figure 1A) . Interestingly, the second most-highly expressed gene in CD40L/IL-21-stimulated normal naïve B cells was IL2RA ( Fig 1A) . IL2RA encodes CD25 (IL-2Rα), which, when complexed with IL-2Rβ and IL-2Rγ/γc, forms the high-affinity IL-2 receptor. Figure 1C ).
IL-21-induced expression of CD25 is impaired on STAT3-deficient naïve B cells
Assessment of the defect in IL2RA upregulation in STAT3 MUT For personal use only. on April 3, 2017. by guest www.bloodjournal.org From As induction of CD25 on activated lymphocytes is transient, 22 
IL-21-induced autocrine IL-10 secretion does not upregulate CD25 on naïve B cells
Another CD40L/IL-21-induced STAT3-dependent gene expressed by naïve B cells was IL10 ( Figure 1A ), which can also activate STAT3 and promote human B-cell differentiation. Figure 3B ). CD25 was expressed equally on both of these populations of cells (Fig 3C) . In contrast, DNAM1 (CD226), which was found to be an IL-21-induced STAT3-dependent gene ( Figure 1A ), was preferentially induced on plasmablasts ( Figure 3D ). Thus, functional STAT3
is required for induction of CD25 on all IL-21-stimulated B cells, rather than being selectively acquired by a distinct subset.
IL-2 promotes IL-21-induced plasmablast generation and Ig secretion by naïve B cells
We IL-2 promotes proliferation of many cell types, including human B cells. 6 As various facets of lymphocyte differentiation are linked to cell division, 15, 16, 19 we established whether the effect of IL-2 on IL-21-stimulated B cells resulted from enhanced proliferation or differentiation. 50 While this list is not exhaustive, these similarities support the evolution of a concurrent role for IL-2 in B-cell maturation, given the essential role of IL-21 in this process.
Overall, our study highlights the utility of examining B cells from patients with monogenic primary immunodeficiencies to not only clarify the roles of particular cytokines in the immune response of normal individuals, but also identify mechanisms underlying the humoral defects characteristic of these conditions. In recent years, genetic mutations underlying many primary immunodeficiencies have been identified. 1, 27, 28, 33, 37 The phenotypic abnormalities in these "Experiments of Nature" demonstrate the non-redundant role for these genes. 
